Form D · Biotechnology

Aegis Spine, Inc.

Englewood, CO · CIK 0001643970

Offering snapshot reported Nov 9, 2021 · SEC filing

Reported sold
$1.6M
Offering amount: $1.6M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 30, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$800K$1.6MOct 25, 2021: $1,100,000.00Oct 25, 2021Nov 9, 2021: $1,600,000.00Nov 9, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,100,000 → $1,600,000
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2021Amendment$1,600,000$500,000vs Oct 25, 20213SEC filing
Oct 25, 2021Initial$1,100,000No comparison2SEC filing
Jun 3, 2015InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-418358

Source: Form D, filed Nov 9, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Youngbo Ahn Director, Executive
Young Bo Ahn Director, Executive
Kyoung Gee Ahn Director
Ui Rok Jung Director, Executive
Gook Jin Kang Director
Jaeshik Lee Director
Wootaek Lim Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9781 S Meridian Blvd #300
Englewood, CO, 80112